Hancock Whitney’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$254K Buy
+11,626
New +$339K ﹤0.01% 666
2021
Q2
– Sell
-21,764
Closed -$516K – 827
2021
Q1
$516K Buy
21,764
+2,965
+16% +$70.4K 0.02% 532
2020
Q4
$377K Buy
18,799
+2,429
+15% +$47.4K 0.01% 608
2020
Q3
$341K Sell
16,370
-5,757
-26% -$104K 0.01% 595
2020
Q2
$387K Buy
22,127
+325
+1% +$6.36K 0.01% 563
2020
Q1
$356K Buy
21,802
+5,102
+31% +$105K 0.01% 584
2019
Q4
$344K Buy
+16,700
New +$278K 0.01% 644

Other funds holding COLL

Hancock Whitney's COLL Position: Q3 2026 in Review

Hancock Whitney opened a new position in Collegium Pharmaceutical (COLL) in Q3 2026: 11,626 shares worth $254K. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: Hancock Whitney previously reported a position in COLL as recently as Q1 2021.

Hancock Whitney first reported a position in COLL in Q4 2019 and has held it in 7 quarters since. The position peaked at $516K in Q1 2021. 239 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Hancock Whitney held 11,626 shares of Collegium Pharmaceutical worth $254K as of Q3 2026.
  • Collegium Pharmaceutical was a new Hancock Whitney position in Q3 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Hancock Whitney's portfolio in Q3 2026, its #666 holding.
  • Hancock Whitney first reported a position in Collegium Pharmaceutical in Q4 2019 and has held it in 7 quarters since.
  • Hancock Whitney's Collegium Pharmaceutical position peaked at $516K in Q1 2021.
  • 239 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Hancock Whitney's 13F filing for Q3 2026, filed 16 Nov 2026.